| pubmed-article:7907073 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7907073 | lifeskim:mentions | umls-concept:C0019158 | lld:lifeskim |
| pubmed-article:7907073 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7907073 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
| pubmed-article:7907073 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:7907073 | pubmed:dateCreated | 1994-4-1 | lld:pubmed |
| pubmed-article:7907073 | pubmed:abstractText | Because the effects of interferon in the presence and absence of cirrhosis are still debated in chronic active hepatitis type non-A, non-B, C (NANB/C), the aim of this study was to determine to what extent the presence of cirrhosis influences the response to interferon. | lld:pubmed |
| pubmed-article:7907073 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7907073 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7907073 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7907073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7907073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7907073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7907073 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7907073 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7907073 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:7907073 | pubmed:issn | 0016-5085 | lld:pubmed |
| pubmed-article:7907073 | pubmed:author | pubmed-author:DhumeauxDD | lld:pubmed |
| pubmed-article:7907073 | pubmed:author | pubmed-author:MétreauJ MJM | lld:pubmed |
| pubmed-article:7907073 | pubmed:author | pubmed-author:Roudot-Thorav... | lld:pubmed |
| pubmed-article:7907073 | pubmed:author | pubmed-author:JouëtPP | lld:pubmed |
| pubmed-article:7907073 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7907073 | pubmed:volume | 106 | lld:pubmed |
| pubmed-article:7907073 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7907073 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7907073 | pubmed:pagination | 686-90 | lld:pubmed |
| pubmed-article:7907073 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:meshHeading | pubmed-meshheading:7907073-... | lld:pubmed |
| pubmed-article:7907073 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7907073 | pubmed:articleTitle | Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C. | lld:pubmed |
| pubmed-article:7907073 | pubmed:affiliation | Département d'Hépatologie, CHU Henri Mondor, Créteil, France. | lld:pubmed |
| pubmed-article:7907073 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7907073 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7907073 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7907073 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7907073 | lld:pubmed |
